Teva Can't Swap Out Expert In HIV Drug Patent Trial
A New York federal judge on Wednesday shot down Teva Pharmaceuticals USA Inc.'s bid to switch out its expert witness for its upcoming trial versus Gilead Sciences Inc. over patents for...To view the full article, register now.
Already a subscriber? Click here to view full article